• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6-羟基多巴胺损伤后黑质多巴胺能神经元退行性改变的时间进程。

Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion.

作者信息

Zuch C L, Nordstroem V K, Briedrick L A, Hoernig G R, Granholm A C, Bickford P C

机构信息

Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.

出版信息

J Comp Neurol. 2000 Nov 20;427(3):440-54. doi: 10.1002/1096-9861(20001120)427:3<440::aid-cne10>3.0.co;2-7.

DOI:10.1002/1096-9861(20001120)427:3<440::aid-cne10>3.0.co;2-7
PMID:11054705
Abstract

The neurotoxin 6-hydroxydopamine (6-OHDA) has been used extensively in animal models of Parkinson's disease. Typically, rodents develop severe unilateral movement deficiencies coupled with apomorphine-induced rotation behavior at least 1 week after an ipsilateral 6-OHDA lesion of the nigrostriatal dopamine (DA) system. The short-term morphological effects of 6-OHDA have not been determined in detail, however, and the exact process by which neurons die has not been elucidated. Thus, novel degenerative markers were used to determine the temporal pattern of acute phenotypic and degenerative alterations following a unilateral 6-OHDA injection into the medial forebrain bundle of adult rats. 6-Hydroxydopamine administration resulted in an increase in terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining as early as 6 hours postlesion. Staining for FluoroJade, a marker of neuronal degeneration, was evident at all time points examined but was maximal at 48 hours. Loss of tyrosine hydroxylase (TH) immunoreactivity began in axons at 6 hours, and progressed to cell bodies at later time points postlesion. Morphological examination of these neurons supported the conclusion of their death via apoptosis. Thus, whereas behavioral manifestations typically become evident 1 week or more following a 6-OHDA lesion, it is evident that nigral cell degeneration begins much earlier. This suggests multiple therapeutic possibilities, including the prevention of apoptosis, in affected neurons.

摘要

神经毒素6-羟基多巴胺(6-OHDA)已广泛应用于帕金森病的动物模型。通常,在黑质纹状体多巴胺(DA)系统同侧进行6-OHDA损伤后至少1周,啮齿动物会出现严重的单侧运动缺陷以及阿扑吗啡诱导的旋转行为。然而,6-OHDA的短期形态学效应尚未得到详细确定,并且神经元死亡的确切过程也尚未阐明。因此,使用新型退行性标记物来确定成年大鼠单侧注射6-OHDA到内侧前脑束后急性表型和退行性改变的时间模式。给予6-羟基多巴胺后,早在损伤后6小时,末端脱氧核苷酸转移酶介导的dUTP缺口末端标记(TUNEL)染色就增加。FluoroJade是一种神经元变性标记物,在所检查的所有时间点都有明显染色,但在48小时时达到最大值。酪氨酸羟化酶(TH)免疫反应性在损伤后6小时开始在轴突中丧失,并在后期进展到细胞体。对这些神经元的形态学检查支持它们通过凋亡死亡的结论。因此,虽然行为表现通常在6-OHDA损伤后1周或更长时间变得明显,但很明显黑质细胞变性在更早的时候就开始了。这提示了多种治疗可能性,包括预防受影响神经元中的细胞凋亡。

相似文献

1
Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion.6-羟基多巴胺损伤后黑质多巴胺能神经元退行性改变的时间进程。
J Comp Neurol. 2000 Nov 20;427(3):440-54. doi: 10.1002/1096-9861(20001120)427:3<440::aid-cne10>3.0.co;2-7.
2
The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.纹状体内单次注射胶质细胞源性神经营养因子对偏侧帕金森病大鼠黑质纹状体多巴胺能系统的影响:使用两种不同剂量的行为学和组织学研究
Neurosci Res. 2000 Apr;36(4):319-25. doi: 10.1016/s0168-0102(00)00097-3.
3
NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53.核因子-κB通过p53促进6-羟基多巴胺诱导的黑质多巴胺能神经元凋亡。
Brain Res. 2007 May 11;1145:190-203. doi: 10.1016/j.brainres.2007.01.130. Epub 2007 Feb 7.
4
Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats.将实体组织腹侧中脑或纹状体移植物移植到黑质内可诱导6-羟基多巴胺损伤大鼠的行为恢复。
Brain Res. 2001 Jan 26;890(1):86-99. doi: 10.1016/s0006-8993(00)03084-5.
5
Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.在帕金森病部分损伤模型中,将神经营养因子或胶质细胞源性神经营养因子注入纹状体或侧脑室后对黑质多巴胺能神经元的保护和再生作用。
Eur J Neurosci. 1999 May;11(5):1554-66. doi: 10.1046/j.1460-9568.1999.00566.x.
6
Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.旋芭蕾舞的猪:一种基于单侧 6-羟多巴胺损毁黑质纹状体通路的大型非灵长类动物模型。
Brain Res Bull. 2018 May;139:167-173. doi: 10.1016/j.brainresbull.2018.02.010. Epub 2018 Feb 17.
7
Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions.纹状体6-羟基多巴胺损伤后成年大鼠黑质中bcl-2、bcl-x和bax细胞分布的改变。
J Neurocytol. 2004 Mar;33(2):213-23. doi: 10.1023/b:neur.0000030696.62829.ec.
8
Prevention of neurotoxin damage of 6-OHDA to dopaminergic nigral neuron by subthalamic nucleus lesions.丘脑底核损伤对6-羟基多巴胺所致黑质多巴胺能神经元神经毒素损伤的预防作用
Stereotact Funct Neurosurg. 2000;75(2-3):66-75. doi: 10.1159/000048385.
9
Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.6-羟基多巴胺纹状体内终末损伤后黑质纹状体多巴胺神经元的进行性退变:大鼠逆行追踪与免疫细胞化学联合研究
Neuroscience. 1994 Mar;59(2):401-15. doi: 10.1016/0306-4522(94)90605-x.
10
Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.利拉鲁肽(一种胰高血糖素样肽-1(GLP-1)受体激动剂)在大鼠帕金森病部分和完全黑质6-羟基多巴胺损伤模型中的特性研究。
Brain Res. 2016 Sep 1;1646:354-365. doi: 10.1016/j.brainres.2016.05.038. Epub 2016 May 24.

引用本文的文献

1
Olfactory Dysfunction in a Novel Model of Prodromal Parkinson's Disease in Adult Zebrafish.成年斑马鱼前驱期帕金森病新模型中的嗅觉功能障碍
Int J Mol Sci. 2025 May 8;26(10):4474. doi: 10.3390/ijms26104474.
2
Insomnia-related rodent models in drug discovery.失眠相关的啮齿动物模型在药物发现中的应用。
Acta Pharmacol Sin. 2024 Sep;45(9):1777-1792. doi: 10.1038/s41401-024-01269-w. Epub 2024 Apr 26.
3
CDNF and MANF in the brain dopamine system and their potential as treatment for Parkinson's disease.大脑多巴胺系统中的CDNF和MANF及其作为帕金森病治疗方法的潜力。
Front Psychiatry. 2023 Jul 24;14:1188697. doi: 10.3389/fpsyt.2023.1188697. eCollection 2023.
4
CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´s disease.CRISPR/sgRNA 导向的协同激活介体 (SAM) 作为治疗帕金森病的工具。
Gene Ther. 2024 Jan;31(1-2):31-44. doi: 10.1038/s41434-023-00414-0. Epub 2023 Aug 4.
5
Inhibition of TRPM2 by AG490 Is Neuroprotective in a Parkinson's Disease Animal Model.AG490 抑制 TRPM2 对帕金森病动物模型具有神经保护作用。
Mol Neurobiol. 2022 Mar;59(3):1543-1559. doi: 10.1007/s12035-022-02723-8. Epub 2022 Jan 8.
6
Retracted: Allopregnanolone restores the tyrosine hydroxylase-positive neurons and motor performance in a 6-OHDA-injected mouse model.撤回:在6-羟基多巴胺注射的小鼠模型中,别孕烯醇酮可恢复酪氨酸羟化酶阳性神经元和运动能力。
CNS Neurosci Ther. 2020 Oct;26(10):1069-1082. doi: 10.1111/cns.13432. Epub 2020 Jun 30.
7
Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum.二十二碳六烯酸通过增加纹状体蛋白激酶活性相关的机制在帕金森病大鼠模型中保护运动功能并增加多巴胺合成。
Neuropharmacology. 2020 May 1;167:107976. doi: 10.1016/j.neuropharm.2020.107976. Epub 2020 Jan 27.
8
Allopregnanolone Modulates GABAAR-Dependent CaMKIIδ3 and BDNF to Protect SH-SY5Y Cells Against 6-OHDA-Induced Damage.别孕烯醇酮调节GABAAR依赖性CaMKIIδ3和脑源性神经营养因子以保护SH-SY5Y细胞免受6-羟基多巴胺诱导的损伤。
Front Cell Neurosci. 2020 Jan 13;13:569. doi: 10.3389/fncel.2019.00569. eCollection 2019.
9
The drug adaptaquin blocks ATF4/CHOP-dependent pro-death Trib3 induction and protects in cellular and mouse models of Parkinson's disease.该药物 adaptaquin 可阻断 ATF4/CHOP 依赖性促死亡 Trib3 的诱导,并在帕金森病的细胞和小鼠模型中发挥保护作用。
Neurobiol Dis. 2020 Mar;136:104725. doi: 10.1016/j.nbd.2019.104725. Epub 2020 Jan 3.
10
Melatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms.褪黑素与帕金森病:分子机制的研究现状与未来展望。
Cell Mol Neurobiol. 2020 Jan;40(1):15-23. doi: 10.1007/s10571-019-00720-5. Epub 2019 Aug 6.